Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study.
Bertrand D, Chavarot N, Olagne J, Greze C, Gatault P, Danthu C, Colosio C, Jaureguy M, Duveau A, Bouvier N, Le Meur Y, Golbin L, Thervet E, Thierry A, François A, Laurent C, Lemoine M, Anglicheau D, Guerrot D. Bertrand D, et al. Among authors: olagne j. Transpl Int. 2024 Dec 6;37:13544. doi: 10.3389/ti.2024.13544. eCollection 2024. Transpl Int. 2024. PMID: 39712083 Free PMC article.
Epidemiological and clinicopathological characteristics of vascular-limited renal AL amyloidosis.
Senot N, Gibier JB, Rabant M, Esteve E, Ferriere E, Dessaix K, Colombat M, Perrochia H, Olagne J, Goujon JM, Wayolle N, Wemeau M, Carpentier B, Pinson P, Beeker N, Bridoux F, Cohen C. Senot N, et al. Among authors: olagne j. Nephrol Dial Transplant. 2024 Dec 12:gfae285. doi: 10.1093/ndt/gfae285. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 39668632
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.
Lafayette R, Tumlin J, Fenoglio R, Kaufeld J, Pérez Valdivia MÁ, Wu MS, Susan Huang SH, Alamartine E, Kim SG, Yee M, Kateifides A, Rice K, Garlo K, Barratt J; SANCTUARY Study Investigators. Lafayette R, et al. J Am Soc Nephrol. 2024 Oct 25. doi: 10.1681/ASN.0000000534. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39455063 No abstract available.
Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased Donor.
Kamar N, Bertrand D, Caillard S, Pievani D, Apithy MJ, Congy-Jolivet N, Chauveau B, Farce F, François A, Delas A, Olagne J, Usureau C, Taupin JL, Guidicelli GL, Couzi L. Kamar N, et al. Among authors: olagne j. Kidney Int Rep. 2024 Jul 30;9(10):2927-2936. doi: 10.1016/j.ekir.2024.07.024. eCollection 2024 Oct. Kidney Int Rep. 2024. PMID: 39430184 Free PMC article.
Non-myeloma light chain cast nephropathy: a multicenter retrospective study on clinicopathological characteristics.
Martins AC, Gibier JB, Ronsin C, Kandel-Aznar C, Moreau A, Chapal M, Francisco D, Sakhi H, Oniszczuk J, Gueguen L, Grunenwald A, Devaux M, Karras A, Royal V, Rabant M, Gnemmi V, Olagne J, Van Huyen JD, Isnard P. Martins AC, et al. Among authors: olagne j. Haematologica. 2024 Aug 1;109(8):2721-2725. doi: 10.3324/haematol.2024.285031. Haematologica. 2024. PMID: 38546694 Free PMC article. No abstract available.
Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.
Chauveau B, Gibier JB, Olagne J, Morel A, Aydin S, McAdoo SP, Viallet N, Perrochia H, Pambrun E, Royal V, Demoulin N, Kemeny JL, Philipponnet C, Hertig A, Boffa JJ, Plaisier E, Domenger C, Brochériou I, Deltombe C, Duong Van Huyen JP, Buob D, Roufosse C, Hellmark T, Audard V, Mihout F, Nasr SH, Renaudin K, Moktefi A, Rabant M; CFPR–French Nephropathology Group. Chauveau B, et al. Among authors: olagne j. Am J Kidney Dis. 2024 Jun;83(6):713-728.e1. doi: 10.1053/j.ajkd.2023.11.003. Epub 2024 Jan 1. Am J Kidney Dis. 2024. PMID: 38171412
Loss of function of XBP1 splicing activity of IRE1α favors B cell tolerance breakdown.
Reuschlé Q, Van Heddegem L, Bosteels V, Moncan M, Depauw S, Wadier N, Maréchal S, De Nolf C, Delgado V, Messai Y, Stolzenberg MC, Magérus A, Werck A, Olagne J, Li Q, Lefevre G, Korganow AS, Rieux-Laucat F, Janssens S, Soulas-Sprauel P. Reuschlé Q, et al. Among authors: olagne j. J Autoimmun. 2024 Jan;142:103152. doi: 10.1016/j.jaut.2023.103152. Epub 2023 Dec 9. J Autoimmun. 2024. PMID: 38071801
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients.
Benotmane I, Olagne J, Gautier-Vargas G, Cognard N, Heibel F, Braun-Parvez L, Keller N, Martzloff J, Perrin P, Pszczolinski R, Moulin B, Fafi-Kremer S, Caillard S. Benotmane I, et al. Among authors: olagne j. Transplantation. 2023 Aug 1;107(8):e215-e218. doi: 10.1097/TP.0000000000004655. Epub 2023 Jul 20. Transplantation. 2023. PMID: 37340538 Free PMC article. No abstract available.
Clinical and Prognostic Factors in Patients with IgG4-Related Kidney Disease.
Chaba A, Devresse A, Audard V, Boffa JJ, Karras A, Cartery C, Deltombe C, Chemouny J, Contamin C, Courivaud C, Duquennoy S, Garcia H, Joly D, Goumri N, Hanouna G, Halimi JM, Plaisier E, Hamidou M, Landron C, Launay D, Lebas C, Legendre M, Masseau A, Mathian A, Mercadal L, Morel N, Mutinelli-Szymanski P, Palat S, Pennaforte JL, Peraldi MN, Pozdzik A, Schleinitz N, Thaunat O, Titeca-Beauport D, Mussini C, Touati S, Prinz E, Faller AL, Richter S, Vilaine E, Ferlicot S, Von-Kotze C, Belliere J, Olagne J, Mesbah R, Snanoudj R, Nouvier M, Ebbo M, Zaidan M. Chaba A, et al. Among authors: olagne j. Clin J Am Soc Nephrol. 2023 Aug 1;18(8):1031-1040. doi: 10.2215/CJN.0000000000000193. Epub 2023 Jun 7. Clin J Am Soc Nephrol. 2023. PMID: 37283461 Free PMC article.
47 results